Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.

Autor: Timmers, G. J.¹, Dijstelbloem, Y.², Simoons-Smit, A. M.³, Touw, D. J.², van Winkelhoff, A. J.⁴, Vandenbroucke-Grauls, C. M. J. E.³, Huijgens, P. C.¹ PC.Huijgens@VUMC.nl

Publikováno v: Bone Marrow Transplantation. Apr2004, Vol. 33 Issue 8, p847-853. 7p. 3 Charts, 1 Graph.

Diffuse large B-cell lymphoma with MYC gene rearrangements:Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature

Autor: de Jonge, A V, Roosma, T J A, Houtenbos, I, Vasmel, W L E, van de Hem, K, de Boer, J P, van Maanen, T, Lindauer-van der Werf, G, Beeker, A, Timmers, G J, Schaar, C G, Soesan, M, Poddighe, P J, de Jong, D, Chamuleau, M E D

Publikováno v: de Jonge, A V, Roosma, T J A, Houtenbos, I, Vasmel, W L E, van de Hem, K, de Boer, J P, van Maanen, T, Lindauer-van der Werf, G, Beeker, A, Timmers, G J, Schaar, C G, Soesan, M, Poddighe, P J, de Jong, D & Chamuleau, M E D 2016, ' Diffuse large B-cell lymphoma with MYC gene rearrangements : Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature ', European Journal of Cancer, vol. 55, pp. 140-146 . https://doi.org/10.1016/j.ejca.2015.12.001

In the past decade, patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) were treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) therapy. Standard treatment is now changing as a result of deeper

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::99edd71a603839fb14183673c4a8f489
https://research.vumc.nl/en/publications/9167d8d4-b68e-4b01-a86a-9aa95ca1fe68

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY.

Autor: Groen, K., Seefat, M., Nasserinejad, K., Stege, C. A., van der Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., van Kampen, R. J., Ludwig, I., Thielen, N., Durdu‐Rayman, N., de Graauw, N. C., van de Donk, N. W., de Waal, E. G., Vekemans, M.‐C., Timmers, G. J., van der Klift, M., Soechit, S., Geerts, P. A.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p797-798, 2p